Our Heart Team leads the region in the treatment of structural heart disease. We were the first in six states — Washington, Wyoming, Alaska, Montana, Idaho and Oregon — to perform transcatheter aortic valve replacement (TAVR), as one of the few sites selected in 2007 to participate in the landmark PARTNER trial. To date, we continue to have the most TAVR experience in the region. Our program offers the newest catheter-based and minimally-invasive therapies available in the US, such as percutaneous mitral valve repair with the Mitraclip, as well as cutting-edge devices available only in ground-breaking clinical trials. This full cadre of treatment for structural heart disease is unmatched by any other center in the WWAMI-OR region.